The experience of using Mexidol in neurological practice

Authors:

O.A. Gromova ¹ , I.Yu. Torshin ¹ , L.V. Stakhovskaya ² , E.G. Pepelyaev ³ , V.A. Semenov ³ , A.G. Nazarenko ⁴

¹ Institute of Pharmacinformatics of the FIC "Informatics and management" of the Russian Academy of Sciences, Moscow, Russia;
² Research Institute of Cerebrovascular Pathology and Stroke FSBEI in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia;
³ FSBEI in Kemerovo State Medical University of the Ministry of Health of Russia, Kemerovo, Russia;
⁴ FGAU "National Medical Research Center for Neurosurgery named after Acad. N.N. Burdenko »Ministry of Health of Russia, Moscow, Russia

Place of publication:
“Journal of Neurology and Psychiatry”, 10, 2018

Summary:
antihypoxic, antioxidant and nootropic effects of Mexidol contribute to improving the condition of patients with cerebrovascular pathology. The results of clinical studies show that the sequential scheme for the use of the drug (first intravenously or intramuscularly, then orally) is effective in the complex therapy of ischemic diseases of the brain, vascular surgery, therapy and rehabilitation of patients with degenerative-dystrophic changes in the spine, with neurodegenerative pathology, infectious neuropathies, a and Also in therapy of neuropsychological and autonomic disorders.